Askew David, Harding Clifford V
Department of Pathology, Case Western Reserve University BRB 925, 10900 Euclid Avenue, Cleveland, OH 44106, USA.
Eur J Immunol. 2002 Oct;32(10):2726-36. doi: 10.1002/1521-4141(2002010)32:10<2726::AID-IMMU2726>3.0.CO;2-8.
MHC class II heterozygotes form haplotype-mismatched heterodimers (combining alpha and beta chains of different alleles). Transfected L-cells expressing Aalpha(d)Abeta(d) or Aalpha(d)Abeta(b) presented exogenous OVA(323-339) peptide to T cells with similar high efficiency, while Aalpha(b)Abeta(b) was less efficient and Aalpha(b)Abeta(d) was ineffective. In contrast, Aalpha(d)Abeta(b) greatly exceeded Aalpha(d)Abeta(d) in processing of intact OVA for presentation of OVA(323-339); Aalpha(b)Abeta(b) was even less efficient and Aalpha(b)Abeta(d) was ineffective. Of macrophages from C57BL/6 (H-2(b)), DBA/2 (H-2(d)) and B6D2F1 (H-2(bxd))mice, B6D2F1 macrophages had highest I-A expression and efficiency for OVA processing or presentation of exogenous OVA(323-339) peptide. Blocking antibodies specific for I-A chains showed that OVA processing by B6D2F1 macrophages primarily involved haplotype-mismatched Aalpha(d)Abeta(b) heterodimers, whereas Aalpha(d)Abeta(d) and Aalpha(b)Abeta(b) contributed more to presentation of exogenous OVA(323-339) peptide. OVA(323-339):I-A complexes were formed from OVA within 10 min with B6D2F1 macrophages but not until 20 min with C57BL/6 or DBA/2 macrophages, and OVA processing was more resistant to inhibition of late endocytic function by hypothermia (18 degrees C) in B6D2F1 than C57BL/6 or DBA/2 macrophages. These results indicate that Aalpha(d)Abeta(b) haplotype-mismatched heterodimers may contribute to antigen processing in early endocytic compartments.
MHC II类杂合子形成单倍型不匹配的异二聚体(由不同等位基因的α链和β链组合而成)。转染表达Aα(d)Aβ(d)或Aα(d)Aβ(b)的L细胞将外源性OVA(323 - 339)肽以相似的高效率呈递给T细胞,而Aα(b)Aβ(b)效率较低,Aα(b)Aβ(d)则无呈递作用。相反,在处理完整OVA以呈递OVA(323 - 339)方面,Aα(d)Aβ(b)大大超过Aα(d)Aβ(d);Aα(b)Aβ(b)效率更低,Aα(b)Aβ(d)无呈递作用。在C57BL/6(H - 2(b))、DBA/2(H - 2(d))和B6D2F1(H - 2(bxd))小鼠的巨噬细胞中,B6D2F1巨噬细胞的I - A表达最高,处理OVA或呈递外源性OVA(323 - 339)肽的效率也最高。针对I - A链的阻断抗体表明,B6D2F1巨噬细胞处理OVA主要涉及单倍型不匹配的Aα(d)Aβ(b)异二聚体,而Aα(d)Aβ(d)和Aα(b)Aβ(b)对外源性OVA(323 - 339)肽的呈递贡献更大。OVA(323 - 339):I - A复合物在10分钟内由B6D2F1巨噬细胞内的OVA形成,而C57BL/6或DBA/2巨噬细胞则要到20分钟才形成,并且与C57BL/6或DBA/2巨噬细胞相比,B6D2F1巨噬细胞的OVA处理对低温(18℃)抑制晚期内吞功能更具抗性。这些结果表明,Aα(d)Aβ(b)单倍型不匹配的异二聚体可能有助于早期内吞区室中的抗原处理。